Post-transplant hypertension in pediatric kidney transplant recipients

Pediatr Nephrol. 2014 Jun;29(6):1075-80. doi: 10.1007/s00467-013-2721-3. Epub 2014 Jan 4.

Abstract

Background: The aim of the study was to investigate the prevalence of post-transplant hypertension (HT) and to assess the blood pressure (BP) of transplanted children with possible risk factors.

Methods: Office and ambulatory blood pressure measurements were performed for each patient.

Results: Twenty-nine patients were included in the study, including 13 patients with newly diagnosed untreated HT according to the results of ambulatory blood pressure monitoring (ABPM). Fourteen patients were on antihypertensive medication, but only in five of these patients was the HT under control; nine patients receiving antihypertensive drugs had uncontrolled HT. Of the 29 patients, two had normotension without any antihypertensive drug(s). Standard deviation scores (SDS) of the nocturnal diastolic BP of the ABPM were positively correlated with the prednisolone dosage per kilogram (p = 0.013, r = 0.45) and negatively correlated with the time period after transplantation (p = 0.024, r = -0.41). Similarly, the SDS of the 24-h diastolic BP was positively correlated with the prednisolone dosage per kilogram (p = 0.006, r = 0.50) and negatively correlated with the time period after transplantation (p = 0.016, r = -0.44). Patients with alternate-day steroid treatment had lower nocturnal systolic (p = 0.016), nocturnal diastolic (p = 0.001) and 24-h diastolic (p = 0.008) SDS when compared to those receiving daily steroid medication.

Conclusion: The prevalence of HT among children after renal transplantation was high among our patient cohort, and steroids had direct impact on nocturnal and diastolic BP.

MeSH terms

  • Adolescent
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory
  • Child
  • Child, Preschool
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Hypertension / epidemiology*
  • Kidney Transplantation / adverse effects*
  • Male
  • Prednisone / therapeutic use*
  • Prevalence
  • Risk Factors
  • Transplant Recipients

Substances

  • Glucocorticoids
  • Prednisone